Cardiovascular risk factor and disease measures from the population assessment of tobacco and health (Path) study

Martin C. Mahoney; Cheryl Rivard; Hoda T. Hammad; Carlos Blanco; James Sargent; Heather L. Kimmel; Baoguang Wang; Michael J. Halenar; Jueichuan Connie Kang; Nicolette Borek; K. Michael Cummings; Kristin Lauten; Maciej L. Goniewicz; Dorothy Hatsukami; Eva Sharma; Kristie Taylor; Andrew Hyland

doi:10.3390/ijerph18147692

Cardiovascular risk factor and disease measures from the population assessment of tobacco and health (Path) study

Martin C. Mahoney, Cheryl Rivard, Hoda T. Hammad, Carlos Blanco, James Sargent, Heather L. Kimmel, Baoguang Wang, Michael J. Halenar, Jueichuan Connie Kang, Nicolette Borek, K. Michael Cummings, Kristin Lauten, Maciej L. Goniewicz, Dorothy Hatsukami, Eva Sharma, Kristie Taylor, Andrew Hyland

Psychiatry & Behavioral Sciences

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

Background: Cardiovascular disease is a key health condition associated with tobacco use; however, clinical measures are not typically possible in population-based studies. In this paper, we assess the reliability and validity of self-reported cardiovascular risk factors and diseases in a large nationally representative study of tobacco use and health outcomes. Methods: This paper analyzes self-reported cardiovascular risk factors and disease among adults age 40 years and older based on U.S. nationally representative data from the Population Assessment of Tobacco and Health (PATH) Study. Prevalence of cardiovascular risk factors (self-reported high blood pressure, high cholesterol, diabetes and family history of premature heart disease, BMI ≥ 35, and tobacco use) and cardiovascular disease (self-reported heart attack, stroke and/or congestive heart failure (CHF)) were considered along with ratings of physical functioning, fatigue, and general health. Results: Selfreported cardiovascular disease was found to be associated with functional health measures (walking up a flight of stairs) and general ratings of health. Prospective analyses found strong correlations between sequential data collection waves for history of hypertension, elevated cholesterol and CHF, while more modest correlations were noted for stroke and heart attack. The overall prevalence of cardiovascular disease and hypertension was comparable to those from the National Health and Nutrition Examination Survey (NHANES). Conclusions: These analyses suggest reliability and concurrent validity regarding self-reported cardiovascular risk factors and disease assessed in the PATH Study.

Original language	English (US)
Article number	7692
Journal	International journal of environmental research and public health
Volume	18
Issue number	14
DOIs	https://doi.org/10.3390/ijerph18147692
State	Published - Jul 2 2021

Bibliographical note

Funding Information:
The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is partnering with the Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP) to conduct the PATH Study under a contract with Westat. The PATH Study is an ongoing, nationally representative, longitudinal cohort study of adults and youth in the United States (U.S.). The study uses audio computer-assisted self-interviews (ACASI) available in English and Spanish to collect self-reported information on tobacco-use patterns and associated health behaviors.

Funding Information:
Funding: This manuscript is supported with Federal funds from the National Institute on Drug Abuse, National Institutes of Health, and the Center for Tobacco Products, Food and Drug Administration, Department of Health and Human Services, under contract to Westat (Contract Nos. HHSN271201100027C and HHSN271201600001C).

Funding Information:
Conflicts of Interest: K. Michael Cummings provides expert testimony on the health effects of smoking and tobacco industry tactics in lawsuits filed against the tobacco industry. He has also received payment as a consultant to Pfizer, Inc., for services on an external advisory panel to assess ways to improve smoking cessation delivery in health care settings. Maciej Goniewicz has received a research grant from Pfizer and served as a member of a scientific advisory board to Johnson & Johnson. Martin C. Mahoney has provided expert testimony on the health effects of smoking in lawsuits filed against the tobacco industry. He has also received research support from Pfizer, Inc., for an on-going clinical trial of smoking cessation, and has previously served on external advisory panels sponsored by Pfizer to promote smoking cessation in clinical settings.

Publisher Copyright:
© 2021 by the authors. Licensee MDPI, Basel, Switzerland.

Keywords

Cardiovascular outcomes
Health behavior
Survey methods
Validity

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Publisher link

10.3390/ijerph18147692

Find It

Find It at U of M Libraries

Cite this

Mahoney, M. C., Rivard, C., Hammad, H. T., Blanco, C., Sargent, J., Kimmel, H. L., Wang, B., Halenar, M. J., Kang, J. C., Borek, N., Cummings, K. M., Lauten, K., Goniewicz, M. L., Hatsukami, D., Sharma, E., Taylor, K., & Hyland, A. (2021). Cardiovascular risk factor and disease measures from the population assessment of tobacco and health (Path) study. International journal of environmental research and public health, 18(14), [7692]. https://doi.org/10.3390/ijerph18147692

Mahoney, MC, Rivard, C, Hammad, HT, Blanco, C, Sargent, J, Kimmel, HL, Wang, B, Halenar, MJ, Kang, JC, Borek, N, Cummings, KM, Lauten, K, Goniewicz, ML, Hatsukami, D, Sharma, E, Taylor, K & Hyland, A 2021, 'Cardiovascular risk factor and disease measures from the population assessment of tobacco and health (Path) study', International journal of environmental research and public health, vol. 18, no. 14, 7692. https://doi.org/10.3390/ijerph18147692

@article{06f01a5f41054e799a5f804212e13cee,

title = "Cardiovascular risk factor and disease measures from the population assessment of tobacco and health (Path) study",

abstract = "Background: Cardiovascular disease is a key health condition associated with tobacco use; however, clinical measures are not typically possible in population-based studies. In this paper, we assess the reliability and validity of self-reported cardiovascular risk factors and diseases in a large nationally representative study of tobacco use and health outcomes. Methods: This paper analyzes self-reported cardiovascular risk factors and disease among adults age 40 years and older based on U.S. nationally representative data from the Population Assessment of Tobacco and Health (PATH) Study. Prevalence of cardiovascular risk factors (self-reported high blood pressure, high cholesterol, diabetes and family history of premature heart disease, BMI ≥ 35, and tobacco use) and cardiovascular disease (self-reported heart attack, stroke and/or congestive heart failure (CHF)) were considered along with ratings of physical functioning, fatigue, and general health. Results: Selfreported cardiovascular disease was found to be associated with functional health measures (walking up a flight of stairs) and general ratings of health. Prospective analyses found strong correlations between sequential data collection waves for history of hypertension, elevated cholesterol and CHF, while more modest correlations were noted for stroke and heart attack. The overall prevalence of cardiovascular disease and hypertension was comparable to those from the National Health and Nutrition Examination Survey (NHANES). Conclusions: These analyses suggest reliability and concurrent validity regarding self-reported cardiovascular risk factors and disease assessed in the PATH Study.",

keywords = "Cardiovascular outcomes, Health behavior, Survey methods, Validity",

author = "Mahoney, {Martin C.} and Cheryl Rivard and Hammad, {Hoda T.} and Carlos Blanco and James Sargent and Kimmel, {Heather L.} and Baoguang Wang and Halenar, {Michael J.} and Kang, {Jueichuan Connie} and Nicolette Borek and Cummings, {K. Michael} and Kristin Lauten and Goniewicz, {Maciej L.} and Dorothy Hatsukami and Eva Sharma and Kristie Taylor and Andrew Hyland",

note = "Funding Information: The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is partnering with the Food and Drug Administration{\textquoteright}s (FDA) Center for Tobacco Products (CTP) to conduct the PATH Study under a contract with Westat. The PATH Study is an ongoing, nationally representative, longitudinal cohort study of adults and youth in the United States (U.S.). The study uses audio computer-assisted self-interviews (ACASI) available in English and Spanish to collect self-reported information on tobacco-use patterns and associated health behaviors. Funding Information: Funding: This manuscript is supported with Federal funds from the National Institute on Drug Abuse, National Institutes of Health, and the Center for Tobacco Products, Food and Drug Administration, Department of Health and Human Services, under contract to Westat (Contract Nos. HHSN271201100027C and HHSN271201600001C). Funding Information: Conflicts of Interest: K. Michael Cummings provides expert testimony on the health effects of smoking and tobacco industry tactics in lawsuits filed against the tobacco industry. He has also received payment as a consultant to Pfizer, Inc., for services on an external advisory panel to assess ways to improve smoking cessation delivery in health care settings. Maciej Goniewicz has received a research grant from Pfizer and served as a member of a scientific advisory board to Johnson & Johnson. Martin C. Mahoney has provided expert testimony on the health effects of smoking in lawsuits filed against the tobacco industry. He has also received research support from Pfizer, Inc., for an on-going clinical trial of smoking cessation, and has previously served on external advisory panels sponsored by Pfizer to promote smoking cessation in clinical settings. Publisher Copyright: {\textcopyright} 2021 by the authors. Licensee MDPI, Basel, Switzerland.",

year = "2021",

month = jul,

day = "2",

doi = "10.3390/ijerph18147692",

language = "English (US)",

volume = "18",

journal = "International Journal of Environmental Research and Public Health",

issn = "1661-7827",

publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",

number = "14",

}

TY - JOUR

T1 - Cardiovascular risk factor and disease measures from the population assessment of tobacco and health (Path) study

AU - Mahoney, Martin C.

AU - Rivard, Cheryl

AU - Hammad, Hoda T.

AU - Blanco, Carlos

AU - Sargent, James

AU - Kimmel, Heather L.

AU - Wang, Baoguang

AU - Halenar, Michael J.

AU - Kang, Jueichuan Connie

AU - Borek, Nicolette

AU - Cummings, K. Michael

AU - Lauten, Kristin

AU - Goniewicz, Maciej L.

AU - Hatsukami, Dorothy

AU - Sharma, Eva

AU - Taylor, Kristie

AU - Hyland, Andrew

N1 - Funding Information: The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), is partnering with the Food and Drug Administration’s (FDA) Center for Tobacco Products (CTP) to conduct the PATH Study under a contract with Westat. The PATH Study is an ongoing, nationally representative, longitudinal cohort study of adults and youth in the United States (U.S.). The study uses audio computer-assisted self-interviews (ACASI) available in English and Spanish to collect self-reported information on tobacco-use patterns and associated health behaviors. Funding Information: Funding: This manuscript is supported with Federal funds from the National Institute on Drug Abuse, National Institutes of Health, and the Center for Tobacco Products, Food and Drug Administration, Department of Health and Human Services, under contract to Westat (Contract Nos. HHSN271201100027C and HHSN271201600001C). Funding Information: Conflicts of Interest: K. Michael Cummings provides expert testimony on the health effects of smoking and tobacco industry tactics in lawsuits filed against the tobacco industry. He has also received payment as a consultant to Pfizer, Inc., for services on an external advisory panel to assess ways to improve smoking cessation delivery in health care settings. Maciej Goniewicz has received a research grant from Pfizer and served as a member of a scientific advisory board to Johnson & Johnson. Martin C. Mahoney has provided expert testimony on the health effects of smoking in lawsuits filed against the tobacco industry. He has also received research support from Pfizer, Inc., for an on-going clinical trial of smoking cessation, and has previously served on external advisory panels sponsored by Pfizer to promote smoking cessation in clinical settings. Publisher Copyright: © 2021 by the authors. Licensee MDPI, Basel, Switzerland.

PY - 2021/7/2

Y1 - 2021/7/2

N2 - Background: Cardiovascular disease is a key health condition associated with tobacco use; however, clinical measures are not typically possible in population-based studies. In this paper, we assess the reliability and validity of self-reported cardiovascular risk factors and diseases in a large nationally representative study of tobacco use and health outcomes. Methods: This paper analyzes self-reported cardiovascular risk factors and disease among adults age 40 years and older based on U.S. nationally representative data from the Population Assessment of Tobacco and Health (PATH) Study. Prevalence of cardiovascular risk factors (self-reported high blood pressure, high cholesterol, diabetes and family history of premature heart disease, BMI ≥ 35, and tobacco use) and cardiovascular disease (self-reported heart attack, stroke and/or congestive heart failure (CHF)) were considered along with ratings of physical functioning, fatigue, and general health. Results: Selfreported cardiovascular disease was found to be associated with functional health measures (walking up a flight of stairs) and general ratings of health. Prospective analyses found strong correlations between sequential data collection waves for history of hypertension, elevated cholesterol and CHF, while more modest correlations were noted for stroke and heart attack. The overall prevalence of cardiovascular disease and hypertension was comparable to those from the National Health and Nutrition Examination Survey (NHANES). Conclusions: These analyses suggest reliability and concurrent validity regarding self-reported cardiovascular risk factors and disease assessed in the PATH Study.

AB - Background: Cardiovascular disease is a key health condition associated with tobacco use; however, clinical measures are not typically possible in population-based studies. In this paper, we assess the reliability and validity of self-reported cardiovascular risk factors and diseases in a large nationally representative study of tobacco use and health outcomes. Methods: This paper analyzes self-reported cardiovascular risk factors and disease among adults age 40 years and older based on U.S. nationally representative data from the Population Assessment of Tobacco and Health (PATH) Study. Prevalence of cardiovascular risk factors (self-reported high blood pressure, high cholesterol, diabetes and family history of premature heart disease, BMI ≥ 35, and tobacco use) and cardiovascular disease (self-reported heart attack, stroke and/or congestive heart failure (CHF)) were considered along with ratings of physical functioning, fatigue, and general health. Results: Selfreported cardiovascular disease was found to be associated with functional health measures (walking up a flight of stairs) and general ratings of health. Prospective analyses found strong correlations between sequential data collection waves for history of hypertension, elevated cholesterol and CHF, while more modest correlations were noted for stroke and heart attack. The overall prevalence of cardiovascular disease and hypertension was comparable to those from the National Health and Nutrition Examination Survey (NHANES). Conclusions: These analyses suggest reliability and concurrent validity regarding self-reported cardiovascular risk factors and disease assessed in the PATH Study.

KW - Cardiovascular outcomes

KW - Health behavior

KW - Survey methods

KW - Validity

UR - http://www.scopus.com/inward/record.url?scp=85110529211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85110529211&partnerID=8YFLogxK

U2 - 10.3390/ijerph18147692

DO - 10.3390/ijerph18147692

M3 - Article

C2 - 34300159

AN - SCOPUS:85110529211

SN - 1661-7827

VL - 18

JO - International Journal of Environmental Research and Public Health

JF - International Journal of Environmental Research and Public Health

IS - 14

M1 - 7692

ER -

Cardiovascular risk factor and disease measures from the population assessment of tobacco and health (Path) study

Abstract

Bibliographical note

Keywords

UN SDGs

Publisher link

Find It

Other files and links

Fingerprint

Cite this